The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells

Journal of Cellular Biochemistry

Volumn 89, Issue 5, 2003, Pages 922-932

  Mahon, Brett D ^a   Wittke, Anja ^a   Weaver, Veronika ^a   Cantorna, Margherita T ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b 126 S Henderson Bldg ^*  (United States)

Author keywords

Cytokines; Gene regulation; T lymphocytes; Vitamin D

Indexed keywords

CD4 ANTIGEN; COLECALCIFEROL; GAMMA INTERFERON; IMMUNOGLOBULIN BINDING FACTOR; IMMUNOGLOBULIN E BINDING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; DOWN REGULATION; DRUG TARGETING; GENE; GENE EXPRESSION REGULATION; IMMUNOREGULATION; INTERLEUKIN 2 RECEPTOR BETA GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; CALCITRIOL; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; INTERFERON TYPE II; INTERLEUKINS; IONOMYCIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, CALCITRIOL; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; TH1 CELLS; TH2 CELLS;

ANIMALIA;

EID: 0043270561     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10580     Document Type: Article

References (34)

1. Armitage RJ, Goff LK, Beverley PC. 1989. Expression and functional role of CD23 on T cells. Eur J Immunol 19:31-35.
2. Baeuerle PA, Henkel T. 1994. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179.
3. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A. 2002. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603-616.
4. Bemiss CJ, Mahon BD, Henry A, Weaver V, Cantorna MT. 2002. Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Arch Biochem Biophys 402:249-254.
5. Bertho JM, Fourcade C, Dalloul AH, Debre P, Mossalayi MD. 1991. Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells. Eur J Immunol 21:1073-1076.
6. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134.
7. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 2001. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974-4980.
8. Cantorna MT, Hayes CE, DeLuca HF. 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861-7864.
9. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 2000. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130:2648-2652.
10. Christopherson KW IInd, Campbell JJ, Hromas RA. 2001. Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration. Blood 98:3562-3568.
11. Delespesse G, Sarfati M. 1988. IgE-binding factors: Their possible role in the regulation of IgE synthesis. Ric Clin Lab 18:75-92.
12. DePinho RA, Schreiber-Agus N, Alt FW. 1991. myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57:1-46.
13. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. 2002. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367-1374.
14. Heid CA, Stevens J, Livak KJ, Williams PM. 1996. Real time quantitative PCR. Genome Res 6:986-994.
15. Hofer T, Nathansen H, Lohning M, Radbruch A, Heinrich R. 2002. GATA-3 transcriptional imprinting in Th2 lymphocytes: A mathematical model. Proc Natl Acad Sci USA 99:9364-9368.
16. Hurlin PJ, Queva C, Eisenman RN. 1997. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 11:44-58.
17. Kowalzick L. 2001. Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis. Br J Dermatol 144(Suppl 58):21-25.
18. Lemire JM. 1992. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49:26-31.
19. Martens CL, Huff TF, Jardieu P, Trounstine ML, Coffman RL, Ishizaka K, Moore KW. 1985. cDNA clones encoding IgE-binding factors from a rat-mouse T-cell hybridoma. Proc Natl Acad Sci USA 82:2460-2464.
20. McHugh RS, Shevach EM. 2002. Cutting edge: Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 168:5979-5983.
21. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. 1993. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178:237-244.
22. Mossalayi MD, Arock M, Bertho JM, Blanc C, Dalloul AH, Hofstetter H, Sarfati M, Delespesse G, Debre P. 1990a. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood 75:1924-1927.
23. Mossalayi MD, Lecron JC, Dalloul AH, Sarfati M, Bertho JM, Hofstetter H, Delespesse G, Debre P. 1990b. Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation. J Exp Med 171:959-964.
24. Raine CS. 1984. Biology of disease. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab Invest 50:608-635.
25. Rengarajan J, Szabo SJ, Glimcher LH. 2000. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21:479-483.
26. Rich BE, Kupper TS. 2001. Cytokines: IL-20 - a new effector in skin inflammation. Curr Biol 11:R531-R534.
27. Rigby WF, Stacy T, Fanger MW. 1984. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74:1451-1455.
28. Rigby WF, Noelle RJ, Krause K, Fanger MW. 1985. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: A cell cycle analysis. J Immunol 135:2279-2286.
29. Rigby WF, Denome S, Fanger MW. 1987. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 79:1659-1664.
30. Schimpl A, Berberich I, Kneitz B, Kramer S, Santner-Nanan B, Wagner S, Wolf M, Hunig T. 2002. IL-2 and autoimmune disease Cytokine Growth Factor Rev 13:369.
31. Schulze A, Downward J. 2001. Navigating gene expression using microarrays - a technology review. Nat Cell Biol 3:E190-E195.
32. Staeva-Vieira TP, Freedman LP. 2002. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 168:1181-1189.
33. Szanya V, Ermann J, Taylor C, Holness C, Fathman CG. 2002. The Subpopulation of CD4(+)CD25(+) Splenocytes That Delays Adoptive Transfer of Diabetes Expresses L-Selectin and High Levels of CCR7. J Immunol 169:2461-2465.
34. Veldman CM, Cantorna MT, DeLuca HF. 2000. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374:334-338.